Scientists have found new, unexpected behaviors when SARS-CoV-2—the virus that causes COVID-19—encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Mar 23, 2021
0
187
The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that the course of the infection ...
Mar 17, 2021
0
29
Collecting liver tissue from 22 postoperative patients with long-term post-Fontan surgery, researchers have found a specific liver fibrosis to develop from the sinusoidal region which is difficult to accurately assess by ...
Mar 8, 2021
0
0
Early detection could reduce the number of African Americans dying from liver cancer, but current screening guidelines may not find cancer soon enough in this community, according to a study published in Cancer in February.
Feb 25, 2021
0
2
A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows.
Dec 15, 2020
0
9
A group of UNSW Sydney researchers has released a groundbreaking report expected to improve the lives of people with bloodborne viruses.
Dec 2, 2020
0
2
(HealthDay)—Cirrhosis disease burden in women has increased substantially since 2000, according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, ...
Nov 23, 2020
0
2
The results are in for the latest Australia-wide sexual health survey of young Aboriginal and Torres Strait Islander people. The GOANNA Survey was led by SAHMRI researchers in partnership with Aboriginal community organizations ...
Nov 17, 2020
0
2
Virologists at Institut national de la recherche scientifique (INRS) have identified a critical role played by a cellular protein in the progression of Hepatitis C virus infection, paving the way for more effective treatment. ...
Oct 22, 2020
0
1
(HealthDay)—By treating or preventing infection, glecaprevir and pibrentasvir (G/P) regimens are promising for increasing access to the transplantation of kidneys from hepatitis C virus (HCV)-positive donors to HCV-negative ...
Oct 14, 2020
0
2
